Litigation/Arbitration

• Representing Ke Holdings Inc. in a securities class action asserting Securities Act and Exchange Act claims in connection with the company’s IPO, SPO, and annual and quarterly financial statements in the S.D.N.Y.
• Representing the underwriting syndicate in securities class actions in connection with DiDi Global Inc.’s IPO
• Representing the underwriting syndicate in securities class actions in connection with Full Truck Alliance Co., Ltd.’s IPO
• Obtained dismissal for the underwriting syndicate in a securities class action in connection with Waterdrop Inc.’s IPO in the Southern District of New York.
• Obtained dismissal for Canaan Inc. in a pair of securities class actions arising from the company’s initial public offering on the NASDAQ.
• Obtained dismissal for Canaan Inc. in a securities class action asserting Exchange Act claims in the Southern District of New York.
• Obtained dismissal for the underwriting syndicate in a securities class action in connection with Zhangmen Education Inc.’s IPO in the Southern District of New York.
• Representing the underwriting syndicate in securities class actions in connection with 17 Education's IPO
• Representing the underwriting syndicate in securities class actions in connection with DouYu’s IPO
• Representing the underwriting syndicate in securities class actions in connection with Qutoutiao’s IPO
• Representing a director of a Chinese multinational company in securities class actions in both state and federal courts in New York
• Represented a Chinese conglomerate and a leading information technology company in the Supreme Court of the State of New York
• Advised a U.S. publicly traded Chinese agriculture company on its securities class action
• Represented a public traded entertainment company in an HKIAC arbitration seated in Hong Kong involving a multimillion dollar claim
• Represented a Chinese real estate group in a US$35 million HKIAC arbitration in relation to disputes arising from alleged breaches of a Master Investment and Shareholder's Agreement
• Advised a high net worth individual on a multi-million dollar contractual dispute before Chinese court
• Advised a US publicly traded company on trade secret infringement matters, including investigation and negotiation
• Advised several multinational companies on various commercial and civil litigation matters in Chinese courts
• Advised a U.S. publicly traded company on its trade secret matters
• Advised companies in a variety of sectors on Chinese law matters in international commercial arbitrations

Compliance

• Represented underwriting syndicates in response to FINRA inquiries concerning litigation arising from PRC-based issuers’ IPOs
• Represented a leading network company to conduct investigation in response to the DOJ's criminal probes
• Conducted an internal investigation for a global supplier of semiconductors
• Conducted an internal investigation, from document collection and review, individual interview, to final report preparation, for a multinational pharmaceutical company with respect to FCPA and anti- corruption compliance
• Conducted an internal investigation including extensive document review and interviews for a multinational real estate company with respect to FCPA and anti-corruption compliance
• Advised a leading multinational medical device company in an internal investigation with respect to FCPA and Chinese anti-corruption law issues
• Advised a Fortune 500 company's audit committee in an internal investigation regarding anti- corruption compliance of its Chinese subsidiary
• Advised management team of a US publicly traded Chinese company in an internal investigation with respect to FCPA issues in China
• Advised a US medical technologies and services provider with FCPA issues in China
• Advised a global investment bank in its FCPA and compliance-related internal investigation regarding government relationship activities
• Advised a US electronics manufacturer in an FCPA-related internal investigation project
• Advised a US publicly traded Chinese company for its compliance program review and revamp
• Provided anti-corruption training to a world leading investment firm

Transactions

• Represented Phoenix Healthcare (01515.HK) on its US$220 million IPO and listing on the Hong Kong Stock Exchange
• Represented Goldman Sachs and Credit Suisse as joint bookrunners in the US$137.7 million initial public offering of Tarena International (Nasdaq: TEDU), a leading provider of professional education services in China
• Represented China Eastern Airlines in connection with its "dim sum" bond offering of RMB2.2 billion 3.875% guaranteed bonds
• Represented a leading Chinese e-commerce company in its investment of a mobile gaming company
• Advised a leading solar panel producer on its debt restructuring
• Represented a leading online education provider on its follow-on offering
• Advised a leading testing service company on its corporate and securities compliance matters